Investor Presentation
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SVNS notes
Solvonis Therapeutics plc (LON: SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce that the Company will be presenting at MelloMonday on Monday 27 January 2025 which will take place as a webinar via Zoom. Anthony Tennyson, CEO, will be presenting and will take questions during the event.
https://melloevents.com/mm270125/ where you can register for a free ticket using the code SHME100.
| www.solvonis.com | X (formerly Twitter) |
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.